Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Journal article
Kapulu MC. et al, (2024), Frontiers in immunology, 15
The Dantu blood group prevents parasite growth in vivo: Evidence from a controlled human malaria infection study.
Journal article
Kariuki SN. et al, (2023), eLife, 12
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Journal article
Odera DO. et al, (2023), Science translational medicine, 15
Sporozoite immunization: innovative translational science to support the fight against malaria.
Journal article
Richie TL. et al, (2023), Expert review of vaccines, 22, 964 - 1007
Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response
Journal article
Kapulu MC. et al, (2022), BMC Infectious Diseases, 22
Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria.
Journal article
Musasia FK. et al, (2022), Nature communications, 13
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop.
Journal article
Williams E. et al, (2022), Vaccine, 40, 3484 - 3489
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.
Journal article
Chi PC. et al, (2022), BMC medical ethics, 23
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.
Journal article
Kimingi HW. et al, (2022), Frontiers in immunology, 13
Complement-mediated serum bactericidal activity of antibodies elicited by the Shigella sonnei GMMA vaccine in adults from a shigellosis-endemic country: Exploratory analysis of a Phase 2a randomized study.
Journal article
Kapulu MC. et al, (2022), Frontiers in immunology, 13
Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt.
Journal article
Mumba N. et al, (2022), Frontiers in public health, 10
Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders
Journal article
Chi PC. et al, (2021), Trials, 22
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia
Journal article
Kunda-Ng'andu EM. et al, (2021), Wellcome Open Research, 6, 31 - 31
Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
Journal article
Kapulu MC. et al, (2021), JCI Insight, 6
Equity for excellence in academic institutions: a manifesto for change
Journal article
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142
Engagement of ethics and regulatory authorities on human infection studies: Proceedings of an engagement workshop in Zambia
Journal article
Kunda-Ng'andu EM. et al, (2021), Wellcome Open Research, 6, 31 - 31
Characterization of Naturally Acquired Immunity to a Panel of Antigens Expressed in Mature P. falciparum Gametocytes.
Journal article
Muthui MK. et al, (2021), Frontiers in cellular and infection microbiology, 11
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group
Journal article
Jamrozik E. et al, (2021), Vaccine, 39, 633 - 640
Shigella-Controlled Human Infection Models: Current and Future Perspectives
Journal article
Clarkson KA. et al, (2021)
Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
Journal article
Jao I. et al, (2020), Bioethics, 34, 819 - 832